Breast Cancer Research and Treatment

, Volume 52, Issue 1–3, pp 175–184 | Cite as

Insulin-like growth factors in human breast cancer

  • Matthew J. Ellis
  • Sara Jenkins
  • John Hanfelt
  • Maura E. Redington
  • Marian Taylor
  • Russel Leek
  • Ken Siddle
  • Adrian Harris


IGF1 and IGF2 are circulating peptide hormones and locally-acting growth factors with both paracrine and autocrine functions. IGF1 and IGF2 signal through a common tyrosine kinase receptor, the insulin- like growth factor 1 receptor (IGF1R), and have mitogenic, cell survival, and insulin-like actions that are essential for embryogenesis, post-natal growth physiology, and breast development. The activities of IGF1 and 2 are tightly-regulated by a network of binding proteins and targeted degradation mechanisms. This complex regulatory system is disrupted in breast cancer, leading to excess IGF1R signaling. Evidence for this statement includes: a) breast cancers are infiltrated with IGF2 expressing stromal cells; b) mannose 6-phosphate/IGF2 receptor (M6P/IGF2R) is mutated in breast cancer, leading to loss of IGF2 degradation; c) IGF1R is overexpressed by malignant breast epithelial cells, and in some cases IGF1R is amplified; and d) complex changes in IGF binding protein expression occur during breast cancer progression which most likely also affect IGF1 and 2 signaling. The clinical importance of these epigenetic and genetic changes has recently been stressed by the finding that IGF1R signaling alters the apoptotic response of breast cancer cells to genotoxic stress and, in addition, IGF1R activation sensitizes cells to estrogen by inducing phosphorylation of the estrogen receptor. As a consequence of these findings, we propose that IGF analysis of breast cancer samples should shift from prognostic studies to an evaluation of IGF ligands, receptors, and binding proteins as resistance/sensitivity markers for radiation, chemotherapy, and endocrine therapy.

breast cancer insulin-like growth factors (IGFs) IGF receptors IGF binding proteins prognosis chemotherapy hormone therapy radiation therapy 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ellis M, Garmroudi F, Cullen K: Insulin receptors (IGF1 and IGF2). In: Bertino J (ed) Encyclopedia of Cancer, Vol 2. Academic Press, San Diego, 1997, pp 927-939Google Scholar
  2. 2.
    Siddle K, Soos M, Field C, et al: Hybrid and atypical insulin/insulin-like growth factor I receptors. Horm Res 41(Suppl 2):56-64, 1994Google Scholar
  3. 3.
    Morrione A, Valentinis B, Xu S-Q, et al: Insulin-like growth factor II stimulates cell proliferation through the insulin receptor. Proc Natl Acad Sci USA 94:3777-3782, 1997Google Scholar
  4. 4.
    Clemmons RD: Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine and Growth Factor Rev 8:45-62, 1997Google Scholar
  5. 5.
    Oh Y: IGF-independent regulation of breast cancer growth by IGF binding proteins. Breast Cancer Res Treat 47:283-293, 1998Google Scholar
  6. 6.
    Ellis MJC, Leav BA, Yang Z, et al: Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells. Mol Endocrinol 10:286-297, 1996Google Scholar
  7. 7.
    Formisano P, Najjar S, Gross C, et al: Receptor-mediated internalization of insulin. Potential role of pp120/HA4, a substrate of the insulin receptor kinase. J Biol Chem 270:24073-24077, 1995Google Scholar
  8. 8.
    Yee D: The insulin-like growth factors and breast cancer — revisited. Breast Cancer Res Treat 47:197-199, 1998Google Scholar
  9. 9.
    Stewart A, Johnson M, May F, et al: Role of insulin-like growth factors and type I insulin-like growth factor receptor in the estrogen stimulated proliferation of human breast cancer cells. J Biol Chem 265:31172-21178, 1990Google Scholar
  10. 10.
    Kleinberg D: Role of IGF-I in normal mammary development. Breast Cancer Res Treat 47:201-208, 1998Google Scholar
  11. 11.
    Ruan W, Newman C, Kleinberg D: Intact and aminoterminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development. Proc Natl Acad Sci USA 89:10872-10876, 1992Google Scholar
  12. 12.
    Ruan W, Catanese V, Wieczorek R, et al: Estradiol enhances the stimulatory effect of insulin-like growth factor-1 (IGF1) on mammary development and growth hormone-induced IGF1 messenger ribonucleic acid. Endocrinol 136:1296-1302, 1995Google Scholar
  13. 13.
    el-Tanani M, Green C: Insulin/IGF-1 modulation of the expression of two estrogen-induced genes in MCF-7 cells. Mol Cell Endocrinol 121:29-35, 1996Google Scholar
  14. 14.
    Lee A, Weng C, Jackson J, et al: Activation of estrogen receptor-mediated gene transcription by IGF1 in human breast cancer cells. J Endocrinol 152:39-47, 1997Google Scholar
  15. 15.
    Hafner F, Holler E, von Angerer E: Effect of growth factors of estrogen mediated gene expression. J Steroid Biochem Molec Biol 58:385-393, 1996Google Scholar
  16. 16.
    Kato S, Endoh H, Masuhiro Y. et al: Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491-1494, 1995Google Scholar
  17. 17.
    Sweeney KJ, Musgrove EA, Watts CK, et al: Cyclins and breast cancer [review]. Cancer Treat Res 83:141-70, 1996Google Scholar
  18. 18.
    Zwijsen R, Wientjens E, Klompmaker R, et al: CDK-independent activation of estrogen receptor by cyclin D1. Cell 88:405-415, 1997Google Scholar
  19. 19.
    Furlanetto R, Harwell S, Frick K: Insulin-like growth factor-I induces cyclin-D1 expression in MG63 human osteosarcoma cells in vitro. Mol Endocrinol 8:510-517, 1994Google Scholar
  20. 20.
    Guvakova M, Surmacz E: Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells. Exp Cell Res 231:149-162, 1997Google Scholar
  21. 21.
    de Cupis A, Noonan D, Pirani P, et al: Comparison between novel steroid-like and conventional nonsteroidal antioestrogens in inhibiting oestradiol-and IGF-I-induced proliferation of human breast cancer-derived cells. Br J Pharmacol 116:2391-2400, 1995Google Scholar
  22. 22.
    Harrington EA, Bennett MR, Fanidi A, et al: c-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 13:3286-3295, 1994Google Scholar
  23. 23.
    Christofori G, Naik P, Hanahan D: A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369:414-418, 1994Google Scholar
  24. 24.
    Baserga R: The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res 55:249-252, 1995Google Scholar
  25. 25.
    Bates P, Fisher R, Ward A, et al: Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II). Br J Cancer 72:1189-1193, 1995Google Scholar
  26. 26.
    Buckbinder L, Talbott R, Velasco-Miguel S, et al: Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377:646-649, 1995Google Scholar
  27. 27.
    Zhang L, Kashanchi F, Zhan Q, et al: Regulation of insulin-like growth factor II P3 promotor by p53: a potential mechanism for tumorigenesis. Cancer Res 56:1367-1373, 1996Google Scholar
  28. 28.
    Webster N, Resnik J, Reichart D, et al: Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer. Cancer Res 56:2781-2788, 1996Google Scholar
  29. 29.
    Sell C, Baserga R, Rubin R: Insulin-like growth factor I (IGF-I) and the IGF-1 receptor prevent etoposide-induced apoptosis. Cancer Res 55:303-306, 1995Google Scholar
  30. 30.
    Turner B, Haffty B, Narayanan L, et al: Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res 57:3079-3083, 1997Google Scholar
  31. 31.
    Rasmussen A, Cullen K: Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors. Breast Cancer Res Treat 47:219-233, 1998Google Scholar
  32. 32.
    Giani C, Cullen KJ, Campani D, et al: IGF-II mRNA and protein are expressed in the stroma of invasive breast cancers: an in situ hybridization and immunohistochemical study. Breast Cancer Res Treat 41:43-50, 1996Google Scholar
  33. 33.
    Cullen KJ, Smith HS, Hill S, et al: Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions. Cancer Res 51:4978-4985, 1991Google Scholar
  34. 34.
    Singer C, Rasmussen A, Smith H, et al: Malignant breast epithelium selects for IGF-II expression in breast stroma. Evidence for paracrine function. Cancer Res 55:2448-2454, 1995Google Scholar
  35. 35.
    Ellis MJC, Singer C, Hornby A, et al: Insulin-like growth factor mediated stromal-epithelial interactions in human breast cancer. Breast Cancer Res Treat 31:249-261, 1994Google Scholar
  36. 36.
    Huynh H, Alpert L, Pollak M: Pregnancy-dependent growth of mammary tumors is associated with overexpression of insulin-like growth factor II. Cancer Res 56:3651-3654, 1996Google Scholar
  37. 37.
    Manni A, Badger B, Wei L, et al: Hormonal regulation of insulin-like growth factor-II and insulin-like growth factor-binding protein expression by breast cancer cells in vivo. Evidence for stromal epithelial interactions. Cancer Res 54:2934-2942, 1994Google Scholar
  38. 38.
    Torapainen E, Lipponen P, Syrjanen K: Expression of insulin-like growth factor II in female breast cancer as related to established prognostic factors and long term prognosis. Anticancer Res 15:2669-2674, 1995Google Scholar
  39. 39.
    Yu H, Levesque M, Khosravi M, et al: Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer. Br J Cancer 74:1242-1247, 1996Google Scholar
  40. 40.
    Foekens JA, Portengen H, van Putten WLJ, et al: Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer. Cancer Res 49:7002-7009, 1989Google Scholar
  41. 41.
    Papa V, Gliozzo B, Clark GM, et al: Insulin-like growth factor receptors are overexpressed and predict a low risk in human breast cancer. Cancer Research 53:3736-3740, 1993Google Scholar
  42. 42.
    Peyrat J, Bonneterre J, Vennin P, et al: Insulin-like growth factor 1 receptors (IGF1-R) and IGF1 in human breast tumors. J Steroid Biochem Mol Biol 37:823-827, 1990Google Scholar
  43. 43.
    Bonneterre J, Peyrat J, Beuscart R, et al: Prognostic significance of insulin-like growth factor 1 receptors in human breast cancer. Cancer Res 50:6931-6935, 1990Google Scholar
  44. 44.
    Surmacz E, Guvakova M, Nolan M, et al: Type I insulin-like growth factor receptor function in breast cancer. Breast Cancer Res Treat 47:255-267, 1998Google Scholar
  45. 45.
    Clarke R, Howell A, Anderson E: Type I insulin-like growth factor receptor gene expression in normal human breast tissue treated with oestrogen and progesterone. Br J Cancer 75:251-257, 1997Google Scholar
  46. 46.
    Almeida A, Muleris M, Dutrillaux B, et al: The insulin-like growth factor I receptor gene is the target for the 15q26 amplicon in breast cancer. Genes Chromosomes Cancer 11:63-65, 1994Google Scholar
  47. 47.
    Happerfield L, Miles D, Barnes D, et al: The localization of the insulin-like growth factor receptor 1 (IGFR1) in benign and malignant breast tissue. Proc AACR Abstract #374, 1997Google Scholar
  48. 48.
    Soos M, Field C, Lammers R, et al: A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. J Biol Chem 267:12955-12963, 1992Google Scholar
  49. 49.
    Railo M, von Smitten K, Pekonen F: The prognostic value of insulin-like growth factor-I receptor in breast cancer patients. Results of a follow-up study on 126 patients. Eur J Cancer 30A:307-311, 1994Google Scholar
  50. 50.
    Hankins GR, De Souza AT, Bentley RC, et al: M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene 12:2003-2009, 1996Google Scholar
  51. 51.
    Oates A, Schumaker L, Jenkins S, et al: The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene. Breast Cancer Res Treat 47:269-281, 1998Google Scholar
  52. 52.
    Claussen M, Buergisser D, Schuller AGP, et al: Regulation of insulin-like growth factor (IGF)-binding protein-6 and mannose 6-phosphate/IGF-II receptor expression in IGF-II-overexpressing NIH 3T3 cells. Mol Endocrinol 9:902-912, 1995Google Scholar
  53. 53.
    Rocha R, Hilsenbeck S, Jackson J, et al: Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease free survival. Clin Cancer Res 3:103-109, 1997Google Scholar
  54. 54.
    Rocha RL, Hilsenbeck SG, Jackson JG, et al: Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features. J Natl Cancer Inst 88:601-606, 1996Google Scholar
  55. 55.
    Pratt S, Pollak M: Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media. Cancer Res 53:5193-5198, 1993Google Scholar
  56. 56.
    Pratt S, Pollak M: Insulin-like growth factor binding protein 3 (IGF-BP3) inhibits estrogen-stimulated breast cancer cell proliferation. Biochem Biophys Res Commun 198:292-297, 1994Google Scholar
  57. 57.
    Huynh H, Yang X, Pollak M: A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780. Cell Growth Differ 7:1501-1506, 1996Google Scholar
  58. 58.
    Yee D, Jackson J, Kozelsky T, et al: Insulin-like growth factor binding protein 1 expression inhibits insulin-like growth factor I action in MCF-7 breast cancer cells. Cell Growth Differ 5:73-77, 1994Google Scholar
  59. 59.
    Gucev Z, Oh Y, Kelley K, et al: Insulin-like growth factor binding protein 3 mediates retinoic acid-and transforming growth factor beta2-induced growth inhibition in human breast cancer cells. Cancer Res 56:1545-1550, 1996Google Scholar
  60. 60.
    Lee A, Hilsenbeck S, Yee D: IGF system components as prognostic markers in breast cancer. Breast Cancer Res Treat 47:295-302, 1998Google Scholar
  61. 61.
    Yu H, Levesque M, Clark G, et al: Prognostic value of PSA in breast cancer: A large US cohort study. Proc AACR 38:Abstract #2924, 1997Google Scholar
  62. 62.
    Yu H, Diamandis E, Levesque M, et al: Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue. Breast Cancer Res Treat 40:171-178, 1996Google Scholar

Copyright information

© Kluwer Academic Publishers 1998

Authors and Affiliations

  • Matthew J. Ellis
  • Sara Jenkins
  • John Hanfelt
  • Maura E. Redington
  • Marian Taylor
  • Russel Leek
  • Ken Siddle
  • Adrian Harris

There are no affiliations available

Personalised recommendations